Durva taila in management of Sadyovrana

An open randomized controlled clinical trial to evaluate efficacy of Durva taila in management of Sadyovrana - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084189

Enrollment

Registered

2025-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 to 60 years 2. Patent of either sex will be taken 3. Subject with Lakshanas of Sadyovrana 4. Wound size up to 5 square centimeters

Exclusion criteria

Exclusion criteria: 1. Patient with infected wound. 2. Patient with known history of DM, HIV, HBsAG, Tuberculosis or any other systemic. 3. Malignant ulcer . 4. Patient with burn. 5. Ulcer due to varicose veins 6. Ulcer due to radiation therapy 7. Vrana on Head, neck region. 8. Features showing gangrene. 9. Any complication will be excluded

Design outcomes

Primary

Measure	Time frame
Durva taila is effective in the management of sadyovarna within 7 daysTimepoint: 7 days	—

Secondary

Measure	Time frame
povidone iodine solution in the management of sadyovarnaTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDR VIJAY DANGE

Hon. Shree Annasaheb Dange Ayurved Medical College Post Graduate And Research Center, Ashta

drvijaydange@gmail.com8600600181

Outcome results